Clinical Trial Update: Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating SYN818 in combination with olaparib for locally advanced or metastatic solid tumors is currently recruiting, including ovarian and brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer
• Solid Tumor

Drugs mentioned

• Olaparib (Olaparib)
• SYN818 (SYN818)

Snippet

Sponsor: Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd | Conditions: Metastatic Solid Tumor, Ovarian Cancer | Phase 1 | Status: RECRUITING